Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data

OBJECTIVE: To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants (NOACs; apixaban, dabigatran, edoxaban and rivaroxaban) versus warfarin in Japanese patients with non-valvular atrial fibrillatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohsaka, Shun, Katada, Jun, Saito, Kumiko, Jenkins, Aaron, Li, Benjamin, Mardekian, Jack, Terayama, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiac Risk Factors and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174060/
https://www.ncbi.nlm.nih.gov/pubmed/32341789
http://dx.doi.org/10.1136/openhrt-2019-001232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174060/
https://www.ncbi.nlm.nih.gov/pubmed/32341789
http://dx.doi.org/10.1136/openhrt-2019-001232

Ejemplares similares